130 related articles for article (PubMed ID: 17503413)
1. Molecular classification and genetic pathways in hyperplastic polyposis syndrome.
Carvajal-Carmona LG; Howarth KM; Lockett M; Polanco-Echeverry GM; Volikos E; Gorman M; Barclay E; Martin L; Jones AM; Saunders B; Guenther T; Donaldson A; Paterson J; Frayling I; Novelli MR; Phillips R; Thomas HJ; Silver A; Atkin W; Tomlinson IP
J Pathol; 2007 Aug; 212(4):378-85. PubMed ID: 17503413
[TBL] [Abstract][Full Text] [Related]
2. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
[TBL] [Abstract][Full Text] [Related]
3. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome.
Boparai KS; Dekker E; Polak MM; Musler AR; van Eeden S; van Noesel CJ
Am J Pathol; 2011 Jun; 178(6):2700-7. PubMed ID: 21641392
[TBL] [Abstract][Full Text] [Related]
4. BRAF mutations in aberrant crypt foci and hyperplastic polyposis.
Beach R; Chan AO; Wu TT; White JA; Morris JS; Lunagomez S; Broaddus RR; Issa JP; Hamilton SR; Rashid A
Am J Pathol; 2005 Apr; 166(4):1069-75. PubMed ID: 15793287
[TBL] [Abstract][Full Text] [Related]
5. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
[TBL] [Abstract][Full Text] [Related]
6. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
[TBL] [Abstract][Full Text] [Related]
7. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
[TBL] [Abstract][Full Text] [Related]
8. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis.
Bossard C; Denis MG; Bézieau S; Bach-Ngohou K; Bourreille A; Laboisse CL; Mosnier JF
Oncol Rep; 2007 Nov; 18(5):1093-7. PubMed ID: 17914558
[TBL] [Abstract][Full Text] [Related]
10. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
Minoo P; Moyer MP; Jass JR
J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169
[TBL] [Abstract][Full Text] [Related]
11. Serrated polyposis syndrome: molecular, pathological and clinical aspects.
Guarinos C; Sánchez-Fortún C; Rodríguez-Soler M; Alenda C; Payá A; Jover R
World J Gastroenterol; 2012 May; 18(20):2452-61. PubMed ID: 22654442
[TBL] [Abstract][Full Text] [Related]
12. Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer.
Will O; Carvajal-Carmona LG; Gorman P; Howarth KM; Jones AM; Polanco-Echeverry GM; Chinaleong JA; Günther T; Silver A; Clark SK; Tomlinson I
Gastroenterology; 2007 Feb; 132(2):527-30. PubMed ID: 17258725
[TBL] [Abstract][Full Text] [Related]
13. Investigating the potential role of genetic and epigenetic variation of DNA methyltransferase genes in hyperplastic polyposis syndrome.
Drini M; Wong NC; Scott HS; Craig JM; Dobrovic A; Hewitt CA; Dow C; Young JP; Jenkins MA; Saffery R; Macrae FA
PLoS One; 2011 Feb; 6(2):e16831. PubMed ID: 21347319
[TBL] [Abstract][Full Text] [Related]
14. A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.
Bongers G; Muniz LR; Pacer ME; Iuga AC; Thirunarayanan N; Slinger E; Smit MJ; Reddy EP; Mayer L; Furtado GC; Harpaz N; Lira SA
Gastroenterology; 2012 Sep; 143(3):730-740. PubMed ID: 22643351
[TBL] [Abstract][Full Text] [Related]
15. Serrated lesions of the appendix in serrated polyposis patients.
Bettington M; Brown IS; Rosty C
Pathology; 2016 Jan; 48(1):30-4. PubMed ID: 27020206
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix.
Yantiss RK; Panczykowski A; Misdraji J; Hahn HP; Odze RD; Rennert H; Chen YT
Am J Surg Pathol; 2007 Nov; 31(11):1742-53. PubMed ID: 18059232
[TBL] [Abstract][Full Text] [Related]
17. Colorectal carcinoma occurring via the adenoma-carcinoma pathway in patients with serrated polyposis syndrome.
Nakamura F; Sato Y; Okamoto K; Fujino Y; Mitsui Y; Kagemoto K; Kawaguchi T; Miyamoto H; Muguruma N; Sonoda T; Tsuneyama K; Takayama T
J Gastroenterol; 2022 Apr; 57(4):286-299. PubMed ID: 35194694
[TBL] [Abstract][Full Text] [Related]
18. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study.
Boparai KS; Mathus-Vliegen EM; Koornstra JJ; Nagengast FM; van Leerdam M; van Noesel CJ; Houben M; Cats A; van Hest LP; Fockens P; Dekker E
Gut; 2010 Aug; 59(8):1094-100. PubMed ID: 19710031
[TBL] [Abstract][Full Text] [Related]
19. Clinical subtypes and molecular characteristics of serrated polyposis syndrome.
Guarinos C; Sánchez-Fortún C; Rodríguez-Soler M; Pérez-Carbonell L; Egoavil C; Juárez M; Serradesanferm A; Bujanda L; Fernández-Bañares F; Cubiella J; de-Castro L; Guerra A; Aguirre E; Herreros-de-Tejada A; Bessa X; Herráiz M; Marín-Gabriel JC; Balmaña J; Cuatrecasas M; Balaguer F; Castells A; Soto JL; Alenda C; Payá A; Jover R
Clin Gastroenterol Hepatol; 2013 Jun; 11(6):705-11; quiz e46. PubMed ID: 23376323
[TBL] [Abstract][Full Text] [Related]
20. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
